If enobosarm is used like ostarin 15-25 mg daily,(with current price 500mg = USD 90 source ) it can make revenues 90usd x 12 months= 1080 USD per treated person annualy. 5 million users x 1080 =5.4 billions. Number of O/S is 160 milions. That means 5400:160 = revenues 33.75 USD/ share.
If after reduction of all distribution and production costs will leave for GTX Inc only 10%..I mean only 10%. then it is 3.375 USD income per share. IF we calculate P/E only 5, then the stock price may reach 5 x 3.375 = 16,87 USD
So yes, if the result is clear success, the pps may reach 1687% if we consider 1 dollar as the base...
Sorry, I was bored so I have played with the numbers
Recent ONCT News
FEATURED Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • Apr 16, 2024 8:52 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM
Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution • AVAI • Apr 16, 2024 8:00 AM
UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM
